Hypertrophic Cardiomyopathy Center and Research Institute
Research + Clinical Trials
In addition to providing world-class care for patients with HCM and their family members, the Tufts Medical Center HCM Center is at the forefront of scientific clinical research aimed at improving diagnosis and management strategies for all patients with hypertrophic cardiomyopathy. Our team is currently involved in a variety of investigative research projects focused on identifying mechanisms of HCM disease expression which may ultimately lead to future therapies to improve the lives of our patients. In addition, we are a leading Center for clinical trials evaluating the efficacy of a number of recent novel drug therapies aimed at mitigating limiting symptoms in patients with HCM.
At Tufts Medical Center, hypertrophic cardiomyopathy is a treatable genetic heart disease compatible with normal or extended longevity (often without the requirement of major treatments). Our national/international HCM Referral Center has established this principle for patients with this genetic disease over the past 15 years.